查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1836899

熱原檢測市場（按產品類型、測試方法、熱原類型、最終用戶和應用）—全球預測 2025-2032

Pyrogen Testing Market by Product Type, Test Method, Pyrogen Type, End User, Application - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，熱原檢測市場將成長至 34.3 億美元，複合年成長率為 12.04%。

主要市場統計數據
基準年2024年 13.8億美元
預計2025年 15.5億美元
預測年份：2032年 34.3億美元
複合年成長率（%） 12.04%

對影響生命科學公司熱原檢測實踐的業務、監管和技術要求的權威介紹

熱原檢測是病人安全、法規遵循和分析創新的交會點。該領域歷來以動物源性檢測為根基，並穩步發展至體外替代方法和自動化分析平台，以降低差異性並提高通量，確保嚴格檢測細菌內毒素和非內毒素熱原，同時簡化流程以滿足緊迫的研發週期和日益嚴格的監管要求。

全球各地的監管機構都明確表達了對檢測方法驗證、試劑和對照品的可追溯性以及檢測工作流程的穩健性的期望。因此，各機構優先投資於標準化檢測方法、記錄在案的品質系統和跨職能培訓。同時，重組試劑和細胞化驗分析等技術進步正在擴展品管和研究團隊可用的套件，從而能夠更特異性檢測不同類型的熱原。

因此，生物製藥開發、合約測試和臨床試驗領域的領導者正在重新評估如何將測試模式與更廣泛的品質架構相結合。這項措施為以下章節奠定了基礎，提供了一個涵蓋營運、監管和技術力量的框架，這些力量正在影響整個生態系統相關人員的短期和中期策略選擇。

監管變化、檢測創新、自動化和供應鏈彈性的整合正在從根本上重塑熱原檢測的執行和採購方式

監管環境的變化、科學創新和供應鏈重組正在改變熱原檢測的格局。首先，監管部門越來越重視與人體相關的檢測方法和嚴格的檢測方法驗證，這推動了替代檢測方法的採用，這些方法可以減少對動物源性試劑的依賴，並提高非內毒素熱原的特異性。其次，檢測化學和自動化技術的進步提高了實驗室的通量，使各機構能夠擴展其檢測能力，同時提高可重複性和資料完整性。

第三，實驗室工作流程的模組化加速了儀器、套件和軟體的整合，使檢測和品管系統之間的資料流更加無縫銜接。第四，試劑創新與下一代檢測原理（例如重組C因子和基於細胞的單核細胞活化檢測）的融合，為檢測方法的差異化開闢了途徑，從而能夠應對複雜的產品矩陣。最後，供應鏈彈性已成為策略重點，相關人員正在多元化供應商關係，並重新評估籌資策略，以減輕中斷的影響。

這些綜合動態正在推動公司圍繞與供應商的夥伴關係關係重組投資，這些供應商可以支援靈活性、監管協調、方法轉移和培訓以及持續的技術支援。累積效應是，市場獎勵那些迅速採用經過驗證的、與人相關的測試解決方案的公司，並懲罰那些推遲現代化測試組合的組織。

2025年美國關稅調整將如何改變採購經濟學、供應商策略以及設備和試劑採購的物流計劃

2025年，美國不斷演變的關稅和貿易措施為依賴跨境採購儀器、套件、試劑和專業服務的機構帶來了層層複雜性。關稅調整影響了進口檢測設備和關鍵試劑的到岸成本，迫使採購團隊重新評估整體擁有成本、供應商選擇標準和庫存策略。一些實驗室透過談判簽訂長期合約來應對，而另一些實驗室則透過多元化供應商，包括國內替代供應商和區域分銷商，以保持營運的連續性。

政策環境也影響自動化系統和輔助設備的資本投資決策。由於進口關稅增加了設備的初始成本，企業通常會推遲評估期，進行更嚴格的內部成本效益分析，並優先採購那些能夠證明產量更高或監管優勢更高的設備。這增加了對全面供應商支援的需求，包括安裝、檢驗包裝和現場服務協議，以降低高額初始投資的風險。

此外，製造商和經銷商已調整合約條款和物流服務，以吸收或減輕關稅帶來的成本衝擊。隨著相關人員尋求可預測的供應鏈，本地倉儲、重新包裝和捆綁檢驗支援等附加價值服務已變得普遍。雖然關稅不會改變選擇檢測方法的基本科學標準，但它正在加速籌資策略的務實調整，強調供應商的可靠性、售後服務支援和本地供應選擇。

細分驅動的可操作分析揭示了產品類型、檢測方法、熱原分類、最終用戶和應用的交叉點，從而影響了測試策略

從細分中獲得的洞察揭示了產品、方法、熱原類型、最終用戶和應用維度之間的差異化動態，為商業和技術策略提供資訊。根據產品類型，對儀器、套件、試劑和服務的市場進行研究。進一步探索自動化系統、培養箱和 LAL 分析儀的儀器。探索固色劑、凝膠凝塊和濁度劑的試劑套件。進一步探索對照、LAL 試劑和 RFC 試劑的試劑。更詳細地探討了諮詢和測試服務的服務。這種以產品為導向的觀點揭示了在自動化、試劑標準化和服務合約方面的投資將對營運可擴展性產生最大影響的地方。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 在生物製藥生產流程中，擴大採用重組 C 因子檢測法進行熱原檢測
  • 新興的微流體LAL 檢測平台可在需要時實現超快速內毒素定量
  • 將即時熱原資料與電腦預測模型結合，實現主動品管
  • USP、EP 和 JP 之間的監管協調將推動全球市場熱原檢測方法的標準化
  • 開發多重熱原和無菌檢測，以簡化大規模生技藥品的放行檢驗流程
  • 增加對連續在線內毒素監測感測器的投資，以實現即時過程分析技術合規性

第6章 2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

8. 熱原檢測市場（依產品類型）

  • 裝置
    • 自動化系統
    • 培養箱
    • 鱟試劑分析儀
  • 套件
    • 顯色
    • 凝膠凝塊
    • 濁度計
  • 試劑
    • 控制
    • 鱟試劑
    • RFC試劑
  • 服務
    • 諮詢服務
    • 測試服務

9. 熱原檢測市場（依測試方法）

  • 鱟血球裂解物
    • 顯色
    • 凝膠凝塊
    • 濁度計
  • 單核細胞活化試驗
  • 重組因子C測定

第 10 章熱原檢測市場（按熱原類型）

  • 細菌內毒素
  • 非內毒素熱原
    • 真菌致熱原
    • 黴漿菌熱支原體
    • 病毒致熱原

第 11 章熱原檢測市場（依最終用戶）

  • 學術研究機構
  • 生技公司
  • 合約研究組織
  • 醫院和診所
  • 製藥商

第12章熱原檢測市場（依應用）

  • 臨床診斷
  • 藥物開發
  • 品管
  • 研究

第13章熱原檢測市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第 14 章熱原檢測市場（按類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 15 章熱原檢測市場（按國家）

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Thermo Fisher Scientific Inc.
    • Charles River Laboratories International, Inc.
    • Merck KGaA
    • Lonza Group AG
    • Eurofins Scientific SE
    • SGS SA
    • WuXi AppTec Co., Ltd.
    • Laboratory Corporation of America Holdings
    • Inotiv, Inc.
    • Pacific BioLabs, Inc.
Product Code: MRR-035AB9C0DA61

The Pyrogen Testing Market is projected to grow by USD 3.43 billion at a CAGR of 12.04% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.38 billion
Estimated Year [2025] USD 1.55 billion
Forecast Year [2032] USD 3.43 billion
CAGR (%) 12.04%

An authoritative primer on the operational, regulatory, and technological imperatives shaping contemporary pyrogen testing practices across life sciences organizations

Pyrogen testing sits at the intersection of patient safety, regulatory compliance, and analytical innovation. Historically rooted in animal-derived assays, the space has steadily evolved toward in vitro alternatives and automated analytical platforms that reduce variability and increase throughput. Today, laboratories and manufacturers face a dual mandate: to ensure rigorous detection of bacterial endotoxins and non-endotoxin pyrogens while simultaneously streamlining processes to meet compressed development timelines and heightened regulatory scrutiny.

Regulatory agencies globally have articulated expectations that emphasize method validation, traceability of reagents and controls, and demonstrable robustness of testing workflows. As a result, organizations have prioritized investments in standardized assays, documented quality systems, and cross-functional training. At the same time, technological advances such as recombinant reagents and cell-based assays have expanded the toolkit available to quality control and research teams, enabling more specific detection of diverse pyrogen classes.

Consequently, leaders in biopharmaceutical development, contract testing, and clinical laboratories are reassessing how testing modalities integrate with broader quality architectures. This introduction lays the groundwork for subsequent sections by framing the operational, regulatory, and technological forces that are shaping immediate and medium-term strategic choices for stakeholders across the ecosystem.

The confluence of regulatory pivoting, assay innovation, automation, and supply chain resilience that is radically reshaping how pyrogen testing is executed and procured

The landscape of pyrogen testing is undergoing transformative shifts driven by regulatory change, scientific innovation, and supply chain realignment. First, regulatory emphasis on human-relevant assays and rigorous method validation has catalyzed adoption of alternative test methods that reduce reliance on animal-derived reagents and offer greater specificity for non-endotoxin pyrogens. Second, advances in assay chemistry and automation have expanded laboratory throughput, allowing organizations to scale testing capacity while improving reproducibility and data integrity.

Third, the modularization of laboratory workflows has accelerated the integration of instruments, kits, and software, enabling more seamless data flows between testing and quality management systems. Fourth, the convergence of reagent innovation and next-generation detection principles - including recombinant factor C and cell-based monocyte activation tests - has created pathways for assay differentiation that can address complex product matrices. Finally, supply chain resilience has ascended as a strategic priority, with stakeholders diversifying supplier relationships and re-evaluating sourcing strategies to mitigate disruptions.

Together, these dynamics are prompting companies to reframe their investments around flexibility, regulatory alignment, and vendor partnerships that can support method transfer, training, and sustained technical support. The cumulative effect is a market that rewards nimble adopters of validated, human-relevant testing solutions and penalizes organizations that delay modernization of their testing portfolios.

How 2025 United States tariff adjustments have reshaped procurement economics, supplier strategies, and logistical planning for instrumentation and reagent sourcing

In 2025, evolving tariff policies and trade measures in the United States have introduced a layer of complexity for organizations that rely on cross-border procurement of instruments, kits, reagents, and specialized services. Tariff adjustments have affected the landed cost of imported laboratory equipment and critical reagents, prompting procurement teams to reassess total cost of ownership, vendor selection criteria, and inventory strategies. Some laboratories have responded by negotiating longer-term contracts, while others have diversified suppliers to include domestic alternatives or regional distributors to preserve continuity of operations.

The policy environment has also influenced decisions around capital expenditures for automated systems and ancillary equipment. When import duties elevate upfront equipment costs, organizations often extend evaluation timelines to perform more rigorous internal cost-benefit analyses and to prioritize purchases that deliver demonstrable throughput gains or regulatory advantages. This, in turn, has increased demand for comprehensive vendor support, including installation, validation packages, and local service agreements that de-risk the higher initial outlay.

Moreover, manufacturers and distributors have adapted contractual terms and logistical offerings to absorb or mitigate tariff-driven cost shocks. Value-added services, such as local warehousing, repackaging, or bundled validation support, have become more common as stakeholders seek predictable supply lines. While tariffs have not altered the fundamental scientific criteria for selecting testing modalities, they have accelerated a pragmatic rebalancing of sourcing strategies that emphasizes supplier reliability, after-sales support, and regional supply options.

Actionable segmentation-driven analysis revealing where product types, assay methods, pyrogen classifications, end users, and applications intersect to influence testing strategies

Insights from segmentation reveal differentiated dynamics across product, method, pyrogen type, end user, and application dimensions that inform commercial and technical strategies. Based on Product Type, market is studied across Instruments, Kits, Reagents, and Services. The Instruments is further studied across Automated Systems, Incubators, and LAL Analyzers. The Kits is further studied across Chromogenic, Gel Clot, and Turbidimetric. The Reagents is further studied across Controls, LAL Reagents, and RFC Reagents. The Services is further studied across Consulting Services and Testing Services. This product-oriented view highlights where investments in automation, reagent standardization, and service contracts are most impactful for operational scalability.

Based on Test Method, market is studied across Limulus Amebocyte Lysate, Monocyte Activation Test, and Recombinant Factor C Assay. The Limulus Amebocyte Lysate is further studied across Chromogenic, Gel Clot, and Turbidimetric. Method-level segmentation underscores the trade-offs between legacy familiarity and the technical advantages of newer, human-relevant assays, and helps stakeholders prioritize validation pathways and method transfer activities.

Based on Pyrogen Type, market is studied across Bacterial Endotoxin and Non-Endotoxin Pyrogens. The Non-Endotoxin Pyrogens is further studied across Fungal Pyrogens, Mycoplasma Pyrogens, and Viral Pyrogens. This distribution of pyrogen types clarifies the necessity for tailored detection approaches and contingency testing strategies for complex biologic matrices. Based on End User, market is studied across Academic & Research Institutes, Biotechnology Companies, Contract Research Organizations, Hospitals & Clinics, and Pharmaceutical Manufacturers. This end-user lens demonstrates how user requirements for throughput, regulatory support, and technical training vary across segments. Based on Application, market is studied across Clinical Diagnostics, Drug Development, Quality Control, and Research. Application-based segmentation draws attention to differential validation burdens and reporting needs that influence instrument selection, kit format preference, and third-party service utilization.

Interpreting these segmentation layers together enables decision-makers to align procurement, validation investments, and supplier partnerships with the nuanced requirements of each testing context. For example, organizations prioritizing high-throughput quality control workflows will weigh automated instruments and robust reagent controls more heavily, whereas academic labs and early-stage developers may prioritize flexible kit formats and method versatility.

Comparative regional analysis explaining how geographic regulatory environments, supply chains, and service ecosystems drive divergent adoption patterns in pyrogen testing

Regional considerations materially shape technology adoption, regulatory alignment, and supply chain architectures for pyrogen testing. In the Americas, centralized regulatory frameworks and a concentration of large pharmaceutical operations have supported rapid uptake of automation and validated alternative assays, with an emphasis on integration into established quality systems and clear documentation for regulatory inspections. By contrast, Europe, Middle East & Africa exhibits heterogeneity in regulatory approaches and infrastructure maturity; this region places a premium on assay flexibility, reagent standardization, and vendor partnerships capable of supporting local validations and multilingual technical services.

In the Asia-Pacific region, a combination of high-volume manufacturing, growing biotech innovation hubs, and a drive toward self-reliance in critical reagent supply has accelerated adoption of both proven and emerging testing modalities. Regional manufacturing centers are increasingly focused on building in-house capabilities for testing and supporting method transfers to global sites. Across all regions, logistical considerations, trade policies, and local service footprints influence procurement timelines and choices of instrument and reagent partners.

Understanding these geographic dynamics is essential for organizations designing global testing strategies, because regulatory expectations, vendor service models, and supply chain resilience vary substantially by region. Companies that harmonize validation strategies, invest in regional technical support, and adapt inventory policies to local logistics will reduce operational risk and accelerate time-to-qualification for new methods and products.

Sophisticated competitive landscape analysis highlighting how instrument vendors, reagent manufacturers, and specialized service providers are redefining value propositions in pyrogen testing

Competitive dynamics in the pyrogen testing ecosystem reflect a mix of established instrument suppliers, specialized reagent manufacturers, and niche service providers that together shape procurement and validation choices. Instrument suppliers differentiate through automation, integration capabilities, and lifecycle service agreements that reduce operational downtime. Reagent manufacturers compete on reagent consistency, traceability, and compatibility with multiple assay formats, while specialized kit providers focus on ease-of-use and rapid deployment for diverse laboratory settings.

Service providers, including testing laboratories and consulting firms, play a critical role in method validation, transfer, and regulatory submission support. Their ability to deliver robust validation packages, cross-validation data, and training accelerates adoption of alternative assays and supports quality systems during inspections. Partnerships between reagent vendors and service providers create bundled offerings that reduce technical friction and shorten implementation timelines.

Innovators in assay chemistry and cell-based detection are gaining commercial traction by offering alternatives that address non-endotoxin pyrogen detection and complex biologic matrices. Strategic collaboration between manufacturers, contract laboratories, and end users is increasingly common, enabling co-development of assays, shared validation efforts, and pilot programs that de-risk scale-up. Organizations evaluating vendors should assess not only technical performance metrics but also the depth of documentation, training resources, and local support networks that collectively determine long-term success.

Practical, prioritized recommendations for laboratory managers and corporate leaders to validate methods, diversify suppliers, and build resilient pyrogen testing operations

Industry leaders should adopt a strategy that balances scientific rigor, operational resilience, and vendor ecosystem optimization. First, prioritize method validation plans that include head-to-head comparisons between legacy and emerging assays and that document equivalency across representative product matrices. Second, formalize supplier qualification criteria that evaluate reagent traceability, installation and validation support for instruments, and local service capabilities to minimize downtime.

Third, invest in modular automation where possible to enable scalable throughput without entangling laboratories in single-vendor lock-in. Fourth, develop inventory and procurement playbooks that address tariff variability and seasonal supply risks, including options for regional sourcing and aggregate contracting across business units. Fifth, engage early with regulatory stakeholders to align submission strategies for alternative assays and to clarify expectations for validation documentation.

Finally, cultivate cross-functional training programs that bring quality, R&D, and operations teams into shared ownership of testing outcomes. These steps will increase organizational agility, reduce time required to qualify new methods, and strengthen the defensibility of testing strategies during regulatory review.

Transparent mixed-methods research approach combining expert interviews, technical literature review, and supplier documentation analysis to derive reproducible insights

This research employed a mixed-methods approach that integrated primary interviews, technical literature review, and supplier documentation analysis to produce actionable insights. Subject-matter experts from quality control laboratories, regulatory affairs, and assay development were engaged to capture experiential knowledge about method transfer challenges, validation expectations, and service provider capabilities. The literature review focused on peer-reviewed studies, regulatory guidance documents, and white papers that describe assay performance characteristics and human-relevant testing strategies.

Supplier documentation and publicly available technical bulletins were analyzed to assess instrument capabilities, reagent compositions, and available validation packages. Where appropriate, comparative analysis of assay principles and workflow integration was conducted to evaluate practical implementation considerations. Data synthesis emphasized recurring themes and divergences in stakeholder perspectives rather than quantitative market aggregates, and the methodology prioritized reproducibility by documenting interview protocols, source categorizations, and criteria for inclusion.

Limitations of the approach include variability in public disclosure practices among vendors and the evolving nature of regulatory guidance. To mitigate these constraints, the study triangulated findings across multiple independent sources and provided clear annotations where interpretations required expert judgment.

Concise strategic conclusions emphasizing validation rigor, supplier resilience, and integrated governance as pillars of effective pyrogen testing programs

In closing, the trajectory of pyrogen testing reflects a steady shift toward assays and workflows that deliver human-relevant sensitivity, operational efficiency, and regulatory defensibility. Stakeholders who align validation strategies, supplier relationships, and automation investments with these priorities will be best positioned to manage the technical and commercial complexities inherent to biologic and pharmaceutical testing. Moreover, a proactive approach to supply chain planning and vendor qualification can buffer operations against tariff-related cost pressures and logistical disruptions.

Decision-makers must view pyrogen testing not as an isolated laboratory function but as an integral component of product quality and patient safety frameworks. Integrating cross-functional governance, investing in scalable technologies, and engaging service partners for validation support will materially reduce time and uncertainty when implementing new testing modalities. The insights contained in the preceding sections aim to equip leadership teams with the strategic perspective necessary to prioritize investments and to operationalize robust, future-ready testing programs.

Taken together, these conclusions underscore the importance of purposeful modernization, disciplined validation, and pragmatic supplier management as the cornerstones of a resilient pyrogen testing strategy.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increasing adoption of recombinant Factor C assays for pyrogen detection in biopharmaceutical manufacturing workflows
  • 5.2. Emergence of microfluidic LAL testing platforms enabling ultra rapid endotoxin quantification at point of need
  • 5.3. Integration of in silico predictive models with real time pyrogen data for proactive quality control
  • 5.4. Regulatory harmonization drive between USP EP and JP to standardize pyrogen test methods across global markets
  • 5.5. Development of multiplex pyrogen and sterility assays to streamline biologics release testing processes at scale
  • 5.6. Growing investment in continuous online endotoxin monitoring sensors for real time process analytical technology compliance

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Pyrogen Testing Market, by Product Type

  • 8.1. Instruments
    • 8.1.1. Automated Systems
    • 8.1.2. Incubators
    • 8.1.3. LAL Analyzers
  • 8.2. Kits
    • 8.2.1. Chromogenic
    • 8.2.2. Gel Clot
    • 8.2.3. Turbidimetric
  • 8.3. Reagents
    • 8.3.1. Controls
    • 8.3.2. LAL Reagents
    • 8.3.3. RFC Reagents
  • 8.4. Services
    • 8.4.1. Consulting Services
    • 8.4.2. Testing Services

9. Pyrogen Testing Market, by Test Method

  • 9.1. Limulus Amebocyte Lysate
    • 9.1.1. Chromogenic
    • 9.1.2. Gel Clot
    • 9.1.3. Turbidimetric
  • 9.2. Monocyte Activation Test
  • 9.3. Recombinant Factor C Assay

10. Pyrogen Testing Market, by Pyrogen Type

  • 10.1. Bacterial Endotoxin
  • 10.2. Non-Endotoxin Pyrogens
    • 10.2.1. Fungal Pyrogens
    • 10.2.2. Mycoplasma Pyrogens
    • 10.2.3. Viral Pyrogens

11. Pyrogen Testing Market, by End User

  • 11.1. Academic & Research Institutes
  • 11.2. Biotechnology Companies
  • 11.3. Contract Research Organizations
  • 11.4. Hospitals & Clinics
  • 11.5. Pharmaceutical Manufacturers

12. Pyrogen Testing Market, by Application

  • 12.1. Clinical Diagnostics
  • 12.2. Drug Development
  • 12.3. Quality Control
  • 12.4. Research

13. Pyrogen Testing Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Pyrogen Testing Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Pyrogen Testing Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Thermo Fisher Scientific Inc.
    • 16.3.2. Charles River Laboratories International, Inc.
    • 16.3.3. Merck KGaA
    • 16.3.4. Lonza Group AG
    • 16.3.5. Eurofins Scientific SE
    • 16.3.6. SGS SA
    • 16.3.7. WuXi AppTec Co., Ltd.
    • 16.3.8. Laboratory Corporation of America Holdings
    • 16.3.9. Inotiv, Inc.
    • 16.3.10. Pacific BioLabs, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PYROGEN TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL PYROGEN TESTING MARKET SIZE, BY TEST METHOD, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL PYROGEN TESTING MARKET SIZE, BY TEST METHOD, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PYROGEN TESTING MARKET SIZE, BY PYROGEN TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL PYROGEN TESTING MARKET SIZE, BY PYROGEN TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PYROGEN TESTING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL PYROGEN TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PYROGEN TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL PYROGEN TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PYROGEN TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS PYROGEN TESTING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL PYROGEN TESTING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. PYROGEN TESTING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. PYROGEN TESTING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. PYROGEN TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL PYROGEN TESTING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL PYROGEN TESTING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL PYROGEN TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL PYROGEN TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL PYROGEN TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL PYROGEN TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL PYROGEN TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL PYROGEN TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL PYROGEN TESTING MARKET SIZE, BY INCUBATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL PYROGEN TESTING MARKET SIZE, BY INCUBATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL PYROGEN TESTING MARKET SIZE, BY INCUBATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL PYROGEN TESTING MARKET SIZE, BY INCUBATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL PYROGEN TESTING MARKET SIZE, BY INCUBATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL PYROGEN TESTING MARKET SIZE, BY INCUBATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL PYROGEN TESTING MARKET SIZE, BY LAL ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL PYROGEN TESTING MARKET SIZE, BY LAL ANALYZERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL PYROGEN TESTING MARKET SIZE, BY LAL ANALYZERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL PYROGEN TESTING MARKET SIZE, BY LAL ANALYZERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL PYROGEN TESTING MARKET SIZE, BY LAL ANALYZERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL PYROGEN TESTING MARKET SIZE, BY LAL ANALYZERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL PYROGEN TESTING MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL PYROGEN TESTING MARKET SIZE, BY KITS, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL PYROGEN TESTING MARKET SIZE, BY KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL PYROGEN TESTING MARKET SIZE, BY KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL PYROGEN TESTING MARKET SIZE, BY KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL PYROGEN TESTING MARKET SIZE, BY KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL PYROGEN TESTING MARKET SIZE, BY KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL PYROGEN TESTING MARKET SIZE, BY KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL PYROGEN TESTING MARKET SIZE, BY CHROMOGENIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL PYROGEN TESTING MARKET SIZE, BY CHROMOGENIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL PYROGEN TESTING MARKET SIZE, BY CHROMOGENIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL PYROGEN TESTING MARKET SIZE, BY CHROMOGENIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL PYROGEN TESTING MARKET SIZE, BY CHROMOGENIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL PYROGEN TESTING MARKET SIZE, BY CHROMOGENIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL PYROGEN TESTING MARKET SIZE, BY GEL CLOT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL PYROGEN TESTING MARKET SIZE, BY GEL CLOT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL PYROGEN TESTING MARKET SIZE, BY GEL CLOT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL PYROGEN TESTING MARKET SIZE, BY GEL CLOT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL PYROGEN TESTING MARKET SIZE, BY GEL CLOT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL PYROGEN TESTING MARKET SIZE, BY GEL CLOT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL PYROGEN TESTING MARKET SIZE, BY TURBIDIMETRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL PYROGEN TESTING MARKET SIZE, BY TURBIDIMETRIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL PYROGEN TESTING MARKET SIZE, BY TURBIDIMETRIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL PYROGEN TESTING MARKET SIZE, BY TURBIDIMETRIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL PYROGEN TESTING MARKET SIZE, BY TURBIDIMETRIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL PYROGEN TESTING MARKET SIZE, BY TURBIDIMETRIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL PYROGEN TESTING MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL PYROGEN TESTING MARKET SIZE, BY REAGENTS, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL PYROGEN TESTING MARKET SIZE, BY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL PYROGEN TESTING MARKET SIZE, BY REAGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL PYROGEN TESTING MARKET SIZE, BY REAGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL PYROGEN TESTING MARKET SIZE, BY REAGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL PYROGEN TESTING MARKET SIZE, BY REAGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL PYROGEN TESTING MARKET SIZE, BY REAGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL PYROGEN TESTING MARKET SIZE, BY CONTROLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL PYROGEN TESTING MARKET SIZE, BY CONTROLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL PYROGEN TESTING MARKET SIZE, BY CONTROLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL PYROGEN TESTING MARKET SIZE, BY CONTROLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL PYROGEN TESTING MARKET SIZE, BY CONTROLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL PYROGEN TESTING MARKET SIZE, BY CONTROLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL PYROGEN TESTING MARKET SIZE, BY LAL REAGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL PYROGEN TESTING MARKET SIZE, BY LAL REAGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL PYROGEN TESTING MARKET SIZE, BY LAL REAGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL PYROGEN TESTING MARKET SIZE, BY LAL REAGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL PYROGEN TESTING MARKET SIZE, BY LAL REAGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL PYROGEN TESTING MARKET SIZE, BY LAL REAGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL PYROGEN TESTING MARKET SIZE, BY RFC REAGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL PYROGEN TESTING MARKET SIZE, BY RFC REAGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL PYROGEN TESTING MARKET SIZE, BY RFC REAGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL PYROGEN TESTING MARKET SIZE, BY RFC REAGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL PYROGEN TESTING MARKET SIZE, BY RFC REAGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL PYROGEN TESTING MARKET SIZE, BY RFC REAGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL PYROGEN TESTING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL PYROGEN TESTING MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL PYROGEN TESTING MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL PYROGEN TESTING MARKET SIZE, BY SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL PYROGEN TESTING MARKET SIZE, BY SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL PYROGEN TESTING MARKET SIZE, BY SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL PYROGEN TESTING MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL PYROGEN TESTING MARKET SIZE, BY SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL PYROGEN TESTING MARKET SIZE, BY CONSULTING SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL PYROGEN TESTING MARKET SIZE, BY CONSULTING SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL PYROGEN TESTING MARKET SIZE, BY CONSULTING SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL PYROGEN TESTING MARKET SIZE, BY CONSULTING SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL PYROGEN TESTING MARKET SIZE, BY CONSULTING SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL PYROGEN TESTING MARKET SIZE, BY CONSULTING SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL PYROGEN TESTING MARKET SIZE, BY TESTING SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL PYROGEN TESTING MARKET SIZE, BY TESTING SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL PYROGEN TESTING MARKET SIZE, BY TESTING SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL PYROGEN TESTING MARKET SIZE, BY TESTING SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL PYROGEN TESTING MARKET SIZE, BY TESTING SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL PYROGEN TESTING MARKET SIZE, BY TESTING SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL PYROGEN TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL PYROGEN TESTING MARKET SIZE, BY TEST METHOD, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL PYROGEN TESTING MARKET SIZE, BY CHROMOGENIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL PYROGEN TESTING MARKET SIZE, BY CHROMOGENIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL PYROGEN TESTING MARKET SIZE, BY CHROMOGENIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL PYROGEN TESTING MARKET SIZE, BY CHROMOGENIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL PYROGEN TESTING MARKET SIZE, BY CHROMOGENIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL PYROGEN TESTING MARKET SIZE, BY CHROMOGENIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL PYROGEN TESTING MARKET SIZE, BY GEL CLOT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL PYROGEN TESTING MARKET SIZE, BY GEL CLOT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL PYROGEN TESTING MARKET SIZE, BY GEL CLOT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL PYROGEN TESTING MARKET SIZE, BY GEL CLOT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL PYROGEN TESTING MARKET SIZE, BY GEL CLOT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL PYROGEN TESTING MARKET SIZE, BY GEL CLOT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL PYROGEN TESTING MARKET SIZE, BY TURBIDIMETRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL PYROGEN TESTING MARKET SIZE, BY TURBIDIMETRIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL PYROGEN TESTING MARKET SIZE, BY TURBIDIMETRIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL PYROGEN TESTING MARKET SIZE, BY TURBIDIMETRIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL PYROGEN TESTING MARKET SIZE, BY TURBIDIMETRIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL PYROGEN TESTING MARKET SIZE, BY TURBIDIMETRIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL PYROGEN TESTING MARKET SIZE, BY MONOCYTE ACTIVATION TEST, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL PYROGEN TESTING MARKET SIZE, BY MONOCYTE ACTIVATION TEST, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL PYROGEN TESTING MARKET SIZE, BY MONOCYTE ACTIVATION TEST, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL PYROGEN TESTING MARKET SIZE, BY MONOCYTE ACTIVATION TEST, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL PYROGEN TESTING MARKET SIZE, BY MONOCYTE ACTIVATION TEST, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL PYROGEN TESTING MARKET SIZE, BY MONOCYTE ACTIVATION TEST, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL PYROGEN TESTING MARKET SIZE, BY RECOMBINANT FACTOR C ASSAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL PYROGEN TESTING MARKET SIZE, BY RECOMBINANT FACTOR C ASSAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL PYROGEN TESTING MARKET SIZE, BY RECOMBINANT FACTOR C ASSAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL PYROGEN TESTING MARKET SIZE, BY RECOMBINANT FACTOR C ASSAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL PYROGEN TESTING MARKET SIZE, BY RECOMBINANT FACTOR C ASSAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL PYROGEN TESTING MARKET SIZE, BY RECOMBINANT FACTOR C ASSAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL PYROGEN TESTING MARKET SIZE, BY PYROGEN TYPE, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL PYROGEN TESTING MARKET SIZE, BY PYROGEN TYPE, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL PYROGEN TESTING MARKET SIZE, BY BACTERIAL ENDOTOXIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL PYROGEN TESTING MARKET SIZE, BY BACTERIAL ENDOTOXIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL PYROGEN TESTING MARKET SIZE, BY BACTERIAL ENDOTOXIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL PYROGEN TESTING MARKET SIZE, BY BACTERIAL ENDOTOXIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL PYROGEN TESTING MARKET SIZE, BY BACTERIAL ENDOTOXIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL PYROGEN TESTING MARKET SIZE, BY BACTERIAL ENDOTOXIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL PYROGEN TESTING MARKET SIZE, BY FUNGAL PYROGENS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL PYROGEN TESTING MARKET SIZE, BY FUNGAL PYROGENS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL PYROGEN TESTING MARKET SIZE, BY FUNGAL PYROGENS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL PYROGEN TESTING MARKET SIZE, BY FUNGAL PYROGENS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL PYROGEN TESTING MARKET SIZE, BY FUNGAL PYROGENS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL PYROGEN TESTING MARKET SIZE, BY FUNGAL PYROGENS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL PYROGEN TESTING MARKET SIZE, BY MYCOPLASMA PYROGENS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL PYROGEN TESTING MARKET SIZE, BY MYCOPLASMA PYROGENS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL PYROGEN TESTING MARKET SIZE, BY MYCOPLASMA PYROGENS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL PYROGEN TESTING MARKET SIZE, BY MYCOPLASMA PYROGENS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL PYROGEN TESTING MARKET SIZE, BY MYCOPLASMA PYROGENS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL PYROGEN TESTING MARKET SIZE, BY MYCOPLASMA PYROGENS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL PYROGEN TESTING MARKET SIZE, BY VIRAL PYROGENS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL PYROGEN TESTING MARKET SIZE, BY VIRAL PYROGENS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL PYROGEN TESTING MARKET SIZE, BY VIRAL PYROGENS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL PYROGEN TESTING MARKET SIZE, BY VIRAL PYROGENS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL PYROGEN TESTING MARKET SIZE, BY VIRAL PYROGENS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL PYROGEN TESTING MARKET SIZE, BY VIRAL PYROGENS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL PYROGEN TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL PYROGEN TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL PYROGEN TESTING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL PYROGEN TESTING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL PYROGEN TESTING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL PYROGEN TESTING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL PYROGEN TESTING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL PYROGEN TESTING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL PYROGEN TESTING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL PYROGEN TESTING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL PYROGEN TESTING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL PYROGEN TESTING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL PYROGEN TESTING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL PYROGEN TESTING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL PYROGEN TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL PYROGEN TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL PYROGEN TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL PYROGEN TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL PYROGEN TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL PYROGEN TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL PYROGEN TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL PYROGEN TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL PYROGEN TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL PYROGEN TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL PYROGEN TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL PYROGEN TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL PYROGEN TESTING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL PYROGEN TESTING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL PYROGEN TESTING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL PYROGEN TESTING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL PYROGEN TESTING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL PYROGEN TESTING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL PYROGEN TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL PYROGEN TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL PYROGEN TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL PYROGEN TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL PYROGEN TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL PYROGEN TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL PYROGEN TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL PYROGEN TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL PYROGEN TESTING MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL PYROGEN TESTING MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL PYROGEN TESTING MARKET SIZE, BY DRUG DEVELOPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL PYROGEN TESTING MARKET SIZE, BY DRUG DEVELOPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL PYROGEN TESTING MARKET SIZE, BY DRUG DEVELOPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL PYROGEN TESTING MARKET SIZE, BY DRUG DEVELOPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL PYROGEN TESTING MARKET SIZE, BY QUALITY CONTROL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL PYROGEN TESTING MARKET SIZE, BY QUALITY CONTROL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL PYROGEN TESTING MARKET SIZE, BY QUALITY CONTROL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL PYROGEN TESTING MARKET SIZE, BY QUALITY CONTROL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL PYROGEN TESTING MARKET SIZE, BY QUALITY CONTROL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL PYROGEN TESTING MARKET SIZE, BY QUALITY CONTROL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL PYROGEN TESTING MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL PYROGEN TESTING MARKET SIZE, BY RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL PYROGEN TESTING MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL PYROGEN TESTING MARKET SIZE, BY RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL PYROGEN TESTING MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL PYROGEN TESTING MARKET SIZE, BY RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL PYROGEN TESTING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL PYROGEN TESTING MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 239. AMERICAS PYROGEN TESTING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 240. AMERICAS PYROGEN TESTING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 241. AMERICAS PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 242. AMERICAS PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 243. AMERICAS PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 244. AMERICAS PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 245. AMERICAS PYROGEN TESTING MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
  • TABLE 246. AMERICAS PYROGEN TESTING MARKET SIZE, BY KITS, 2025-2032 (USD MILLION)
  • TABLE 247. AMERICAS PYROGEN TESTING MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
  • TABLE 248. AMERICAS PYROGEN TESTING MARKET SIZE, BY REAGENTS, 2025-2032 (USD MILLION)
  • TABLE 249. AMERICAS PYROGEN TESTING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 250. AMERICAS PYROGEN TESTING MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 251. AMERICAS PYROGEN TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
  • TABLE 252. AMERICAS PYROGEN TESTING MARKET SIZE, BY TEST METHOD, 2025-2032 (USD MILLION)
  • TABLE 253. AMERICAS PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, 2018-2024 (USD MILLION)
  • TABLE 254. AMERICAS PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, 2025-2032 (USD MILLION)
  • TABLE 255. AMERICAS PYROGEN TESTING MARKET SIZE, BY PYROGEN TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. AMERICAS PYROGEN TESTING MARKET SIZE, BY PYROGEN TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. AMERICAS PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, 2018-2024 (USD MILLION)
  • TABLE 258. AMERICAS PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, 2025-2032 (USD MILLION)
  • TABLE 259. AMERICAS PYROGEN TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 260. AMERICAS PYROGEN TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 261. AMERICAS PYROGEN TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 262. AMERICAS PYROGEN TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 263. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 267. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 268. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 269. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
  • TABLE 270. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY KITS, 2025-2032 (USD MILLION)
  • TABLE 271. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
  • TABLE 272. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY REAGENTS, 2025-2032 (USD MILLION)
  • TABLE 273. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 274. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 275. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
  • TABLE 276. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY TEST METHOD, 2025-2032 (USD MILLION)
  • TABLE 277. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, 2018-2024 (USD MILLION)
  • TABLE 278. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, 2025-2032 (USD MILLION)
  • TABLE 279. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY PYROGEN TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY PYROGEN TYPE, 2025-2032 (USD MILLION)
  • TABLE 281. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, 2018-2024 (USD MILLION)
  • TABLE 282. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, 2025-2032 (USD MILLION)
  • TABLE 283. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 284. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 285. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 286. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 287. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 288. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 289. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 291. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 292. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 293. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
  • TABLE 294. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY KITS, 2025-2032 (USD MILLION)
  • TABLE 295. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
  • TABLE 296. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY REAGENTS, 2025-2032 (USD MILLION)
  • TABLE 297. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 298. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 299. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
  • TABLE 300. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY TEST METHOD, 2025-2032 (USD MILLION)
  • TABLE 301. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, 2018-2024 (USD MILLION)
  • TABLE 302. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, 2025-2032 (USD MILLION)
  • TABLE 303. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY PYROGEN TYPE, 2018-2024 (USD MILLION)
  • TABLE 304. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY PYROGEN TYPE, 2025-2032 (USD MILLION)
  • TABLE 305. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, 2018-2024 (USD MILLION)
  • TABLE 306. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, 2025-2032 (USD MILLION)
  • TABLE 307. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 308. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 309. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 310. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 311. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 312. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 313. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 314. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 315. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 316. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 317. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
  • TABLE 318. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY KITS, 2025-2032 (USD MILLION)
  • TABLE 319. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
  • TABLE 320. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY REAGENTS, 2025-2032 (USD MILLION)
  • TABLE 321. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 322. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 323. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
  • TABLE 324. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY TEST METHOD, 2025-2032 (USD MILLION)
  • TABLE 325. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, 2018-2024 (USD MILLION)
  • TABLE 326. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, 2025-2032 (USD MILLION)
  • TABLE 327. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY PYROGEN TYPE, 2018-2024 (USD MILLION)
  • TABLE 328. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY PYROGEN TYPE, 2025-2032 (USD MILLION)
  • TABLE 329. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, 2018-2024 (USD MILLION)
  • TABLE 330. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, 2025-2032 (USD MILLION)
  • TABLE 331. EUROPE, MIDDLE EA